Patents by Inventor Michael Min Xu

Michael Min Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10894076
    Abstract: The present invention provides a composition comprising a GLP-1 receptor agonist and a glucagon receptor agonist and an application of the composition. More specifically, the present invention provides a pharmaceutical composition comprising a pharmaceutically effective amount of the GLP-1 receptor agonist and the glucagon receptor agonist, wherein the GLP-1 receptor agonist and the glucagon receptor agonist independently form a conjugate with a hydrophilic polymer, or the GLP-1 receptor agonist and the glucagon receptor agonist jointly form a conjugate with the hydrophilic polymer.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: January 19, 2021
    Assignee: PEGBIO CO., LTD.
    Inventors: Michael Min Xu, Wei Lv, Yinghui Zhang, Xiaosu Luo
  • Publication number: 20190134161
    Abstract: The present invention provides a composition comprising a GLP-1 receptor agonist and a glucagon receptor agonist and an application of the composition. More specifically, the present invention provides a pharmaceutical composition comprising a pharmaceutically effective amount of the GLP-1 receptor agonist and the glucagon receptor agonist, wherein the GLP-1 receptor agonist and the glucagon receptor agonist independently form a conjugate with a hydrophilic polymer, or the GLP-1 receptor agonist and the glucagon receptor agonist jointly form a conjugate with the hydrophilic polymer.
    Type: Application
    Filed: December 28, 2016
    Publication date: May 9, 2019
    Applicant: PEGBIO CO., LTD.
    Inventors: Michael Min Xu, Wei Lv, Yinghui Zhang, Xiaosu Luo
  • Patent number: 7144978
    Abstract: Multi-armed functional polyethylene glycol polymers with active terminal groups may be used in conjugation with small molecule pharmaceuticals, proteins and peptides to enhance half-life and bioavailability of the drug and improve solubility, stability and immunological competence.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: December 5, 2006
    Assignee: Pan Asia Bio Co., Ltd.
    Inventors: Junlian Huang, Michael Min Xu, Xiaojian Hu, Yuhong Xu